कंपनी का अवलोकन
Forian Inc. operates within the healthcare sector, specifically focusing on the health information services industry, where it provides a comprehensive suite of data management capabilities alongside information and analytics solutions designed to optimize and measure operational, clinical, and financial performance for clients in life science, healthcare, and financial services. The company develops commercial and real world evidence products that assist customers in managing complex data environments to derive actionable insights. Forian Inc. currently maintains a market capitalization of $66.86M, generates annual revenue of $30.26M over the trailing twelve months, and employs a workforce of 50 individuals. These financial figures indicate that the company operates as a small-cap entity with a specialized niche focus, suggesting a business model that prioritizes high-value, specialized services over broad market dominance. The relatively low employee count combined with a specific revenue stream highlights a lean operational structure typical of early-stage technology firms in the health information services space.
वित्तीय स्वास्थ्य
The company reported a revenue of $30.26M for the trailing twelve months, yet it recorded a net income of $-2,874,042 and an EBITDA of $-3,550,385, revealing a significant gap between top-line sales and profitability that points to substantial operating expenses or non-operating costs eroding margins. Despite the negative net income and EBITDA, Forian Inc. maintains a positive free cash flow of $3.90M, which provides essential financial flexibility to fund operations, invest in technology development, or manage working capital without immediate reliance on external equity financing. The gross margin stands at 53.2%, indicating a favorable pricing power or high-value service delivery in its core data management business, while the operating margin is negative at -24.4% and the profit margin is -9.5%, signaling that the company has not yet achieved economies of scale to cover all overhead costs relative to its sales volume. In terms of balance sheet strength, the company holds $31.55M in cash against $12,137 in debt, resulting in a conservative debt-to-equity ratio of 0.04 that suggests minimal leverage and low financial risk. The current ratio of 2.96 further underscores strong short-term liquidity, as the company possesses nearly three times the current assets necessary to cover its short-term liabilities. Return on Equity is negative at -9.6% and Return on Assets is -5.1%, which reveals that management effectiveness in generating returns on shareholders' capital and assets is currently hindered by the ongoing operational losses despite the robust cash position.
मूल्यांकन आकलन
Forian Inc. presents a valuation scenario where the trailing P/E ratio is N/A due to negative earnings, while the forward P/E is listed at 23.78, implying that the market anticipates a significant turnaround in profitability to justify earnings expectations in the coming fiscal year. The price-to-book ratio is 2.23, indicating that the market values the company at more than double its tangible book value, which suggests a premium assigned to its intangible assets, intellectual property, and growth potential rather than its current liquidation value. Alternative valuation metrics show a price-to-sales ratio of 2.21 and an EV/EBITDA of -9.93, suggesting that investors are pricing the stock based on revenue multiples rather than earnings power, a common practice for growth-oriented companies in the healthcare sector that are currently unprofitable. Regarding price momentum, the stock trades between a 52-week high of $2.71 and a 52-week low of $1.64, with the current market price positioning the asset within this historical volatility range. The beta value of 0.99 indicates that the stock's price volatility moves in tandem with the broader market, meaning it does not exhibit significantly higher or lower risk characteristics compared to the overall market index.
Growth & Income
Forian Inc. demonstrated robust revenue growth of 37.0% year-over-year, while earnings growth is N/A due to the company's current lack of profitability, implying that the expansion in sales has not yet translated into bottom-line gains due to high fixed costs or investment in growth initiatives. As a non-dividend payer, the company reports a dividend yield of N/A and a payout ratio of 0.0%, meaning it does not distribute cash to shareholders but instead retains earnings to reinvest into its data management solutions and analytics platforms. This strategy of reinvestment rather than dividend distribution is characteristic of a growth-stage company seeking to compound value internally rather than providing immediate income to investors. The overall growth and income profile for Forian Inc. is defined by high revenue expansion and zero dividend income, creating a capital appreciation opportunity that relies entirely on future operational success to convert into positive net income and shareholder returns.